4.26
price down icon5.12%   -0.23
after-market After Hours: 4.38 0.12 +2.82%
loading
Nrx Pharmaceuticals Inc stock is traded at $4.26, with a volume of 719.39K. It is down -5.12% in the last 24 hours and up +255.00% over the past month. NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
See More
Previous Close:
$4.49
Open:
$4.31
24h Volume:
719.39K
Relative Volume:
0.74
Market Cap:
$51.52M
Revenue:
-
Net Income/Loss:
$-30.15M
P/E Ratio:
-1.065
EPS:
-4
Net Cash Flow:
$-21.66M
1W Performance:
+13.30%
1M Performance:
+255.00%
6M Performance:
+70.40%
1Y Performance:
+0.09%
1-Day Range:
Value
$4.05
$4.48
1-Week Range:
Value
$3.72
$6.01
52-Week Range:
Value
$1.10
$7.333

Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile

Name
Name
Nrx Pharmaceuticals Inc
Name
Phone
484-254-6134
Name
Address
1201 ORANGE STREET, WILMINGTON
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
NRXP's Discussions on Twitter

Compare NRXP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NRXP
Nrx Pharmaceuticals Inc
4.26 51.52M 0 -30.15M -21.66M -4.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
416.96 107.38B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
693.23 76.18B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
659.81 39.45B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
249.16 32.14B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
112.76 27.03B 3.30B -501.07M 1.03B -2.1146

Nrx Pharmaceuticals Inc Stock (NRXP) Latest News

pulisher
Jan 15, 2025

NRx Pharmaceuticals Strengthens Board with Key Financial and Healthcare Veterans After $27M Deal - StockTitan

Jan 15, 2025
pulisher
Jan 15, 2025

NRx Pharmaceuticals Board Member Resigns, New Member to be Appointed - Defense World

Jan 15, 2025
pulisher
Jan 14, 2025

NRx Pharmaceuticals director resigns, new nominee expected By Investing.com - Investing.com South Africa

Jan 14, 2025
pulisher
Jan 14, 2025

NRx Pharmaceuticals director resigns, new nominee expected - Investing.com

Jan 14, 2025
pulisher
Jan 14, 2025

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Alert Investors to Sanjay Gupta/CNN Program on Ketamine, Featuring Kadima Neuropsychiatry Institute Founder Dr. David Feifel - StreetInsider.com

Jan 14, 2025
pulisher
Jan 14, 2025

NRx Pharmaceuticals' Future CMO Featured on CNN Special About Ketamine Therapy - StockTitan

Jan 14, 2025
pulisher
Jan 13, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces it has Filed an Application with NASDAQ to Uplist to the NASDAQ Global Market from the NASDAQ Capital Market - Quantisnow

Jan 13, 2025
pulisher
Jan 13, 2025

NRx Pharmaceuticals Pursues NASDAQ Global Market Uplisting to Boost Institutional Access - StockTitan

Jan 13, 2025
pulisher
Jan 13, 2025

NRx Pharmaceuticals, Inc. announced that it expects to receive $2.0002 million in funding - Marketscreener.com

Jan 13, 2025
pulisher
Jan 12, 2025

NRx Pharmaceuticals Announces Entry into Share Purchase Agreement with HOPE Therapeutics and JGS Holdings LLC - Defense World

Jan 12, 2025
pulisher
Jan 10, 2025

NRXPNRX Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Jan 10, 2025
pulisher
Jan 10, 2025

NRx Pharmaceuticals Secures $25M Backing for Massive Mental Health Clinic Expansion - StockTitan

Jan 10, 2025
pulisher
Jan 08, 2025

D. Boral Capital Reaffirms “Buy” Rating for NRx Pharmaceuticals (NASDAQ:NRXP) - Defense World

Jan 08, 2025
pulisher
Jan 08, 2025

Best Momentum Stocks to Buy for January 6th - MSN

Jan 08, 2025
pulisher
Jan 07, 2025

Agreement for $27 Million in Funding for Expanding Clinic Acquisitions and Operations, Plus New Drug Application for Treatment of Suicidal Depression: NRx Pharmaceuticals, Inc. Stock Symbol: NRXP - Barchart

Jan 07, 2025
pulisher
Jan 07, 2025

Stock market news: Hoth Therapeutics +184.32%, DatChat +79.85% among top gainers during mid day trading - Business Upturn

Jan 07, 2025
pulisher
Jan 07, 2025

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventiona - StreetInsider.com

Jan 07, 2025
pulisher
Jan 07, 2025

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTS - PR Newswire

Jan 07, 2025
pulisher
Jan 07, 2025

Agreement for $27 Million in Funding for Expanding Clinic - openPR

Jan 07, 2025
pulisher
Jan 06, 2025

NRx stock rallies 35% on equity purchases, clinic acquisition - MSN

Jan 06, 2025
pulisher
Jan 06, 2025

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:N - GuruFocus.com

Jan 06, 2025
pulisher
Jan 06, 2025

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Term Sheet for $27 Million in Funding for HOPE Clinic Acquisitions and Pharmaceutical Operations - PR Newswire

Jan 06, 2025
pulisher
Jan 06, 2025

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announce Dura Medical as the Expected Initial Florida Acquisition for its Planned International Network of Interventional Psychiatry Clinics - PR Newswire

Jan 06, 2025
pulisher
Jan 06, 2025

NRx Pharmaceuticals (NASDAQ:NRXP) and Lexaria Bioscience (NASDAQ:LEXX) Head to Head Contrast - Defense World

Jan 06, 2025
pulisher
Jan 05, 2025

HOPE Therapeutics, Inc., an NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Subsidiary, Will Host an Investor Workshop for Qualified Institutional Investors at the Mar-A-Lago Club During the Week of January 6, 2025 - PR Newswire

Jan 05, 2025
pulisher
Jan 03, 2025

NRx Pharmaceuticals (NRXP) Rises Before An Investor Workshop - Stocks Telegraph

Jan 03, 2025
pulisher
Jan 03, 2025

HOPE Therapeutics Plans $100M Revenue Mental Health Clinic Acquisition Strategy at Mar-a-Lago Workshop - StockTitan

Jan 03, 2025
pulisher
Jan 03, 2025

Acquisition of Kadima Neuropsychiatry Institute for CNS & - openPR

Jan 03, 2025
pulisher
Jan 02, 2025

Hope Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Kadima Neuropsychiatry Institute as the Expected First Acquisition for its International Network of Interventional Psychiatry Clinics - The Malaysian Reserve

Jan 02, 2025
pulisher
Jan 02, 2025

NRx Pharma unit to acquire psychiatric facility Kadima - MSN

Jan 02, 2025
pulisher
Jan 02, 2025

NRx Pharmaceuticals Stock Rises 33% on Psychiatry Clinic Acquisition - MarketWatch

Jan 02, 2025
pulisher
Jan 02, 2025

NRx Pharmaceuticals Announces Agreement with LifeSci Associates to Provide Financial Services and Support - GuruFocus.com

Jan 02, 2025
pulisher
Jan 02, 2025

NRx Pharma to buy Kadima psychiatric clinic (NRXP:NASDAQ) - Seeking Alpha

Jan 02, 2025
pulisher
Jan 02, 2025

NRx Pharmaceuticals (NASDAQ:NRXP) Earns Buy Rating from D. Boral Capital - Defense World

Jan 02, 2025
pulisher
Jan 01, 2025

NRx Pharmaceuticals (NASDAQ:NRXP) Given “Buy” Rating at D. Boral Capital - Defense World

Jan 01, 2025
pulisher
Dec 31, 2024

Walt Disney Company (DIS-N) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 31, 2024

Crowdstrike Holdings Inc (CRWD-Q) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 31, 2024

New Drug Application to the FDA for the Treatment of Suicidal - openPR

Dec 31, 2024
pulisher
Dec 30, 2024

NRx Pharmaceuticals Takes Bold Step Toward FDA Approval for NRX-100 in Treatment of Suicidal Depression - Tandav Media

Dec 30, 2024
pulisher
Dec 30, 2024

Best Momentum Stocks to Buy for December 30th - Yahoo Finance

Dec 30, 2024
pulisher
Dec 30, 2024

NRx Pharmaceuticals seeks FDA nod for suicidal depression drug - Investing.com India

Dec 30, 2024
pulisher
Dec 30, 2024

NRx Pharmaceuticals seeks FDA nod for suicidal depression drug By Investing.com - Investing.com Nigeria

Dec 30, 2024
pulisher
Dec 30, 2024

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression - StreetInsider.com

Dec 30, 2024
pulisher
Dec 24, 2024

New Strong Buy Stocks for December 24th - MSN

Dec 24, 2024
pulisher
Dec 19, 2024

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter and Year to Date 2024 Financial Results on November 14, 2024 - The Eastern Progress Online

Dec 19, 2024
pulisher
Dec 19, 2024

NRX Pharmaceuticals chairman Jonathan Javitt buys $46,800 in stock By Investing.com - Investing.com Canada

Dec 19, 2024
pulisher
Dec 18, 2024

NRX Pharmaceuticals chairman Jonathan Javitt buys $46,800 in stock - Investing.com India

Dec 18, 2024
pulisher
Dec 17, 2024

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic - Kilgore News Herald

Dec 17, 2024
pulisher
Dec 17, 2024

Meta Platforms Inc (META-Q) QuotePress Release - The Globe and Mail

Dec 17, 2024
pulisher
Dec 12, 2024

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics - The Eastern Progress Online

Dec 12, 2024
pulisher
Dec 12, 2024

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Conference Call to Discuss Third Quarter and Year to Date 2024 Financial Results to November 18, 2024 - The Eastern Progress Online

Dec 12, 2024

Nrx Pharmaceuticals Inc Stock (NRXP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$21.22
price up icon 4.89%
$30.95
price up icon 0.68%
$72.47
price up icon 0.01%
$366.39
price up icon 1.31%
biotechnology ONC
$205.34
price up icon 1.79%
$112.76
price down icon 0.80%
Cap:     |  Volume (24h):